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1. INTRODUCTION {#cpr12736-sec-0001}
===============

Scoliosis is defined as an abnormal lateral curvature of the spine with the Cobb angle \>10 degree and inevitably accompanied by varying degree of hyperlordosis and rotational deformity.[1](#cpr12736-bib-0001){ref-type="ref"}, [2](#cpr12736-bib-0002){ref-type="ref"}, [3](#cpr12736-bib-0003){ref-type="ref"} Scoliosis has several subtypes including idiopathic, syndromic, neuromuscular and congenital scoliosis, among which adolescent idiopathic scoliosis (AIS) is the most common and affects about 1%‐4% of adolescents around the world.[4](#cpr12736-bib-0004){ref-type="ref"}, [5](#cpr12736-bib-0005){ref-type="ref"} Congenital spinal malformation occurring during embryogenesis leading to mixed segmental vertebral deformity is another common cause of scoliosis.[6](#cpr12736-bib-0006){ref-type="ref"} The aetiologies of scoliosis are multifactorial, involving both environmental (eg, maternal alcohol use and vitamin deficiency during pregnancy for congenital scoliosis) and genetic (eg single‐nucleotide polymorphisms \[SNPs\] in *LBX1*, *GPR126*, *BNC2* and *PAX1* for idiopathic scoliosis) factors.[7](#cpr12736-bib-0007){ref-type="ref"}, [8](#cpr12736-bib-0008){ref-type="ref"}, [9](#cpr12736-bib-0009){ref-type="ref"}, [10](#cpr12736-bib-0010){ref-type="ref"}, [11](#cpr12736-bib-0011){ref-type="ref"}, [12](#cpr12736-bib-0012){ref-type="ref"}, [13](#cpr12736-bib-0013){ref-type="ref"}, [14](#cpr12736-bib-0014){ref-type="ref"}, [15](#cpr12736-bib-0015){ref-type="ref"}, [16](#cpr12736-bib-0016){ref-type="ref"} However, the exact cellular and molecular mechanisms linking these aetiological factors to the development of scoliosis remain largely unknown. Thus, it is crucial to study the molecular pathogenesis of scoliosis so as to identify novel molecular markers for early identification of patients at risk and the development of mechanism‐driven therapeutics.

Non‐coding RNAs (ncRNAs) are an important class of regulatory, non‐protein‐coding transcripts, which encompass three major subclasses, namely long ncRNAs (lncRNAs), microRNAs (miRNAs) and circular RNAs (circRNAs).[17](#cpr12736-bib-0017){ref-type="ref"}, [18](#cpr12736-bib-0018){ref-type="ref"}, [19](#cpr12736-bib-0019){ref-type="ref"}, [20](#cpr12736-bib-0020){ref-type="ref"} While the mechanism by which miRNAs regulate gene expression is relatively straightforward (ie, guiding the RNA‐induced silencing complex to target mRNAs through base‐pairing to induce their degradation and/or inhibit their translation),[21](#cpr12736-bib-0021){ref-type="ref"} lncRNAs and circRNAs could regulate gene expression at multiple levels (eg, DNA methylation, histone modification, recruitment of transcriptional factors, sponging of miRNAs and regulation of mRNA stability for lncRNAs; sponging of miRNAs, transcription regulation, modulation of alternative splicing, direct interactions with RNA‐binding proteins and protein translation via rolling circle amplification for circRNAs).[22](#cpr12736-bib-0022){ref-type="ref"}, [23](#cpr12736-bib-0023){ref-type="ref"} ncRNAs are essential for the regulation and execution of key cellular processes, including proliferation, apoptosis, autophagy, differentiation, metabolism, migration, differentiation and invasion.[24](#cpr12736-bib-0024){ref-type="ref"}, [25](#cpr12736-bib-0025){ref-type="ref"}, [26](#cpr12736-bib-0026){ref-type="ref"}, [27](#cpr12736-bib-0027){ref-type="ref"}, [28](#cpr12736-bib-0028){ref-type="ref"}, [29](#cpr12736-bib-0029){ref-type="ref"}, [30](#cpr12736-bib-0030){ref-type="ref"} It therefore comes as no surprise that ncRNAs are deregulated in most, if not all, kinds of diseases, including neoplastic, inflammatory and metabolic diseases.[31](#cpr12736-bib-0031){ref-type="ref"}, [32](#cpr12736-bib-0032){ref-type="ref"}, [33](#cpr12736-bib-0033){ref-type="ref"}, [34](#cpr12736-bib-0034){ref-type="ref"}, [35](#cpr12736-bib-0035){ref-type="ref"} From a clinical perspective, the frequent alteration of ncRNA abundance in the body fluid, such as saliva, blood and urine, during diseases make this class of molecules promising candidates for development into biomarkers for early diagnosis and prognostication.[36](#cpr12736-bib-0036){ref-type="ref"}, [37](#cpr12736-bib-0037){ref-type="ref"}, [38](#cpr12736-bib-0038){ref-type="ref"}

A growing body of evidence now suggests that deregulated expression of ncRNAs is a key to the development of orthopaedic diseases, including osteosarcoma, osteoporosis, osteoarthritis and intervertebral disc degeneration.[25](#cpr12736-bib-0025){ref-type="ref"}, [28](#cpr12736-bib-0028){ref-type="ref"}, [39](#cpr12736-bib-0039){ref-type="ref"}, [40](#cpr12736-bib-0040){ref-type="ref"}, [41](#cpr12736-bib-0041){ref-type="ref"} Emerging evidence also suggests that ncRNAs are deregulated in scoliosis and functionally participate in its pathogenesis.[42](#cpr12736-bib-0042){ref-type="ref"}, [43](#cpr12736-bib-0043){ref-type="ref"} Here, we first summarize recent ncRNA profiling studies in scoliosis followed by discussing specific ncRNAs that are functionally important to the development of scoliosis. The potential clinical utilities of ncRNAs as molecular biomarkers and therapeutic targets for the management of scoliosis are also addressed.

2. ncRNA EXPRESSION PROFILING IN SCOLIOSIS {#cpr12736-sec-0002}
==========================================

Profiling the expression of ncRNAs with whole‐transcriptome sequencing, microarray or PCR array followed by confirmation with reverse transcription (RT)‐quantitative PCR is the most common approach to identify and validate deregulated ncRNAs in specific disease states.[17](#cpr12736-bib-0017){ref-type="ref"}, [44](#cpr12736-bib-0044){ref-type="ref"}, [45](#cpr12736-bib-0045){ref-type="ref"} In this regard, multiple groups of investigators have embarked on profiling studies to depict the transcriptome‐wide expression landscape of ncRNAs in scoliosis (Table [1](#cpr12736-tbl-0001){ref-type="table"}).

###### 

ncRNAs expression profiles in scoliosis

+-----+---------------------------+------------------------------------+----------------------------------------+--------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------+------------------------------------------+
| No. | Method                    | Sample                             | Microarray filtering criteria          | Deregulated                                                                                      | Upregulated                                     | Downregulated     | References                               |
+=====+===========================+====================================+========================================+==================================================================================================+=================================================+===================+==========================================+
| 1   | Microarray,               | AIS cases                          | fold change more than 2 and *P* \< .05 | 546 mRNAs                                                                                        | 512 mRNAs                                       | 34 mRNAs          | [42](#cpr12736-bib-0042){ref-type="ref"} |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     | RT‐PCR                    | healthy children                   |                                        | 139 lncRNAs                                                                                      | 118 lncRNAs                                     | ENST00000414894.1 |                                          |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     |                           |                                    |                                        |                                                                                                  | TCONS00028768                                   | ENST00000440778.1 |                                          |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     |                           |                                    |                                        |                                                                                                  | ENST00000440778.1                               |                   |                                          |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     |                           |                                    |                                        |                                                                                                  | NR024075                                        |                   |                                          |
+-----+---------------------------+------------------------------------+----------------------------------------+--------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------+------------------------------------------+
| 2   | Microarray,               | AIS cases                          | *P* \< .05; Fold change \> 2           |                                                                                                  | miR‐1226‐5p, miR‐27a‐5p, miR‐223‐5p, miR‐122‐5p | miR‐671‐5p,       | [44](#cpr12736-bib-0044){ref-type="ref"} |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     | RT‐PCR                    | healthy children                   |                                        |                                                                                                  |                                                 | miR‐1306‐3p       |                                          |
+-----+---------------------------+------------------------------------+----------------------------------------+--------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------+------------------------------------------+
| 3   | Microarray,               | Patients with Friedreich\'s ataxia | *P* \< .05; Fold change \> 1.5         | miR‐128‐3p, miR‐625‐3p, miR‐130b‐5p, miR‐151a‐5p, miR‐330‐3p, miR‐323a‐3p, miR‐142‐3p, miR‐16‐5p |                                                 |                   | [48](#cpr12736-bib-0048){ref-type="ref"} |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     | RT‐PCR                    |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
+-----+---------------------------+------------------------------------+----------------------------------------+--------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------+------------------------------------------+
| 4   | Transcriptome sequencing, | Degenerate disc tissues            | Fold change \> 2                       | 749 mRNAs,                                                                                       | 194 mRNAs,                                      | 555 mRNAs,        | [43](#cpr12736-bib-0043){ref-type="ref"} |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     | RT‐PCR                    |                                    |                                        | 70 circRNAs,                                                                                     | 185 lncRNAs,                                    | 500 lncRNAs,      |                                          |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     |                           |                                    |                                        | 685 lncRNAs,                                                                                     | 35 circRNAs,                                    | 35 circRNAs,      |                                          |
|     |                           |                                    |                                        |                                                                                                  |                                                 |                   |                                          |
|     |                           |                                    |                                        | 56 miRNAs                                                                                        | 53 miRNAs                                       | 3 miRNAs          |                                          |
+-----+---------------------------+------------------------------------+----------------------------------------+--------------------------------------------------------------------------------------------------+-------------------------------------------------+-------------------+------------------------------------------+
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Liu and colleagues performed Agilent mRNA and lncRNA human Array V3.0 microarray to identify the expression patterns of mRNA and lncRNA in peripheral blood of healthy children and AIS cases.[46](#cpr12736-bib-0046){ref-type="ref"} Their data demonstrated that a total of 546 mRNAs and 139 lncRNAs were differentially expressed between healthy control and AIS cases, among which NR024075 and ENST00000440778.1 were the most upregulated and downregulated lncRNAs, respectively. RT‐qPCR confirmed the significant upregulation of ENST00000414894.1, TCONS 00028768 and ENST00000602322.1 and downregulation of ENST000004407‐78.1 in AIS. Among the 546 differentially expressed mRNAs, 34 mRNAs were downregulated in the AIS group, while 512 mRNAs were overexpressed. Furthermore, the correlations between lncRNA expression levels and clinical features of scoliosis were explored. The investigators found that the expression levels of TCONS00028768 and ENST00000440778.1 were correlated with the height of scolitic patients. Patients with higher ENST00000602322.1 expression levels were also younger at onset. Lower expression of ENST00000414894.1 was observed in scoliotic patients with Cobb angles more than 40 degrees while higher expression of ENST00000440778.1 was correlated with higher Risser grade.

Efforts have also been put forth to profile circulating miRNAs in patients with scoliosis. García‐Giménez and colleagues profiled circulating miRNAs by RNA sequencing in 17 AIS patients and 10 healthy controls, followed by validation with RT‐qPCR in 30 AIS patients and 13 healthy controls.[47](#cpr12736-bib-0047){ref-type="ref"} Their data suggested that circulating miRNAs of AIS patients exhibited differential abundance profiles as compared with healthy subjects. miR‐122‐5p, miR‐27a‐5p and miR‐223‐5p were found to be more abundant in patients with AIS. These 3 miRNAs together with another miRNA miR‐1306‐3p as a combined miRNA signature could differentiate AIS patients from controls with an area under the curve (AUC) value of 0.95. These data suggested that circulating miRNAs may be used as potential diagnostic biomarkers for AIS. In another study, Seco‐Cervera and colleagues profiled circulating miRNAs by RNA sequencing in 17 controls and 25 patients with Friedreich\'s ataxia (FRDA), which is an autosomal recessive neurodegenerative mitochondrial disease with non‐neurological features including scoliosis, cardiac complications and diabetes.[24](#cpr12736-bib-0024){ref-type="ref"}, [48](#cpr12736-bib-0048){ref-type="ref"} The differential abundance of miR‐128‐3p, miR‐625‐3p, miR‐130b‐5p, miR‐151a‐5p, miR‐330‐3p, miR‐323a‐3p, miR‐142‐3p, and miR‐16‐5p was further confirmed by RT‐qPCR. Nevertheless, differentially abundant circulating miRNAs identified in the studies by García‐Giménez et al and Seco‐Cervera et al did not overlap, which might be explained by the aetiological heterogeneity of scoliosis.

Besides using human samples for ncRNA profiling, differential expression of ncRNAs pertinent to the pathogenesis of scoliosis can be inferred from related animal models. Our previous study used whole‐transcriptome sequencing to determine ncRNA and mRNA expression profiles in rat embryos with vitamin A deficiency (VAD)‐induced congenital scoliosis as compared to control.[42](#cpr12736-bib-0042){ref-type="ref"} A total of 56 miRNAs, 70 circRNAs, 685 lncRNAs and 749 mRNAs were found to be significantly differentially expressed between the two groups, among which there were 555 downregulated and 194 upregulated mRNAs; 500 downregulated and 185 upregulated lncRNAs; 35 downregulated and 35 upregulated circRNAs; and 3 downregulated and 53 upregulated miRNAs in the VAD embryos. Bioinformatic analysis is the involvements of forkhead box O (FoxO), phosphatidylinositol 3‐kinase (PI3K)‐Akt, mammalian target of rapamycin (mTOR), epidermal growth factor receptor (EGFR) and Wnt signalling pathways in the pathogenesis of VAD‐induced congenital scoliosis. The deregulation of selected ncRNAs (miRNAs: miR‐187‐5p and miR‐466c‐3p; lncRNAs: NONRATG027649.1 and NONRATG024332.1; circRNAs: chr5_50556456_51183813 and chr15_23792823_23793342) was confirmed with RT‐qPCR.

These profiling studies, mostly performed with peripheral blood of patients, collectively suggested that ncRNAs are deregulated in scoliosis. It is expected that the use of other tissue types, such as bone, paravertebral muscle and cartilage, collected during surgery for transcriptome‐wide profiling will depict a much clearer picture of ncRNA deregulation in a cell‐type‐specific manner that will guide the choice of cell and animal models for subsequent functional studies.

3. FUNCTIONAL ROLES OF KEY ncRNAS IN SCOLIOSIS {#cpr12736-sec-0003}
==============================================

3.1. miR‐4300 {#cpr12736-sec-0004}
-------------

Ogura and colleagues performed the genome‐wide association study (GWAS) on 2142 patients with AIS, among which 1105 exhibited clinical progression while the remaining 832 were assigned to the non‐progression group.[49](#cpr12736-bib-0049){ref-type="ref"} After replicating the association of top 10 candidate loci using an independent cohort of AIS patients (323 progressed and 283 non‐progressed patients), strong association of chromosome 11q14.1 containing the SNP rs1828853 with AIS progression was identified. SNPs exhibiting strong linkage disequilibrium with rs1828853 were found to be clustered in putative enhancer region in intron 1 of *MIR4300HG*, which codes for miR‐4300. Among SNPs in linkage disequilibrium with rs1828853, only rs35333564 showed the allelic difference in the binding to the nuclear proteins, with the risk allele associated with a decrease in enhancer activity. These data suggest that rs1828853 could alter miR‐4300 expression to dictate the risk of AIS progression.

3.2. miR‐145 {#cpr12736-sec-0005}
------------

Disturbance of bone turnover in patients is implicated in the pathogenesis of AIS. Zhang and their colleagues used miRNA microarray to profile miRNA expression in bone tissues of iliac crest from AIS patients compared to control subjects and identified miR‐145 as an AIS‐associated miRNA.[50](#cpr12736-bib-0050){ref-type="ref"} RT‐qPCR confirmed the aberrant upregulation of miR‐145 in the bones of AIS patients as well as the derived cultured bone cells. Strong positive correlation existed between miR‐145 and CTNNB1 (encoding β‐catenin) in primary osteoblasts, in which persistent activation of β‐catenin impaired osteocyte functions. Ectopic expression of miR‐145 induced β‐catenin expression whereas knockdown expression of miR‐145 decreased the active β‐catenin. Knockdown expression of miR‐145 also suppressed the formation of active β‐catenin/Tcf4 complex without influencing Tcf4 expression. Moreover, downregulating miR‐145 expression restored the normal expression of osteocyte markers, including osteoprotegerin (OPG), the transmembrane glycoprotein E11 and secretion of sclerostin (SOST) in AIS osteoblasts.

3.3. H19/miR‐675‐5p {#cpr12736-sec-0006}
-------------------

Imbalance between two sides of paravertebral muscle is implicated in the onset and progression of scoliosis. Jiang and colleagues performed RNA sequencing to identify differentially expressed transcripts in the 5 pairs of paravertebral muscle of AIS cases.[51](#cpr12736-bib-0051){ref-type="ref"} A total of 40 differentially expressed genes overrepresented in the peroxisome proliferator‐activated receptor (PPAR) signalling pathway and biosynthesis of unsaturated fatty acids were identified between the concave‐ and convex‐sided paravertebral muscles. Among the PPAR‐related genes, ADIPOQ, FABP4 and MSTN showed the most significant upregulation in concave‐sided muscle tissue. In contrast, H19, a lncRNA important for skeletal muscle differentiation and regeneration, was downregulated. The differential expression of ADIPOQ and H19 was further found to be correlated with earlier age of disease onset and larger spinal curve. Mechanistically, the authors found that miR‐675‐5p encoded by *H19* was an upstream negative regulator of the ADIPOQ expression as confirmed by negative correlation between miR‐675‐5p and ADIPOQ mRNA levels in muscle biopsies and the direct binding of miR‐675‐5p to the 3′‐untranslated region of ADIPOQ mRNA. Further upstream analysis revealed that differential CCCTC‐binding factor (CCTF) occupancy in the H19 imprinting control region was responsible the differential expression of H19. This study highlighted the potential involvement of the CCTF‐H19/miR‐675‐5p‐ADIPOQ axis in AIS development.

3.4. LncAIS {#cpr12736-sec-0007}
-----------

Abnormal osteogenic differentiation of mesenchymal stem cells (MSCs) is known to be associated with AIS. Zhang and colleagues performed microarray with bone marrow (BM)‐MSCs isolated from 12 AIS patients and 5 controls and identified 1483 deregulated lncRNAs---718 downregulated and 765 overexpressed.[52](#cpr12736-bib-0052){ref-type="ref"} The reduction of the top downregulated lncRNA ENST00000453347 designated as lncAIS was further confirmed by RT‐qPCR in 30 AIS patients and 20 healthy controls. Functionally, knockdown of lncAIS inhibited osteogenic differentiation of BM‐MSCs in vitro and bone formation in vivo. Mechanistically, lncAIS was found to interact with the NF90 to enhance HOXD8 stability which promoted RUNX2 to induce osteogenic differentiation. This signalling cascade was impaired in AIS where lncAIS was downregulated. Collectively, these data supported the functional involvement of lncAIS in AIS pathogenesis.

3.5. SULT1C2A and miR‐466c‐5p {#cpr12736-sec-0008}
-----------------------------

Our team has shown that embryonic expression of the lncRNA SULT1C2A was decreased whereas miR‐466c‐5p was upregulated in the rat model of vitamin A deficiency‐induced congenital scoliosis.[43](#cpr12736-bib-0043){ref-type="ref"} Somitogenesis‐related genes, such as Foxo4, Sox9, Pax1 and Nkx3‐2, were downregulated on gestational day 9 upon maternal vitamin A deficiency. In this regard, reduced expression of SULT1C2A was found to increase the availability of miR‐466c‐5p and thereby decreasing Foxo4 expression. Spatiotemporal alterations of the SULT1C2A‐miR‐466c‐5p‐Foxo4 axis were paralleled by changes in phosphoinositide 3‐kinase (PI3K) expression and AKT phosphorylation. These data suggested that the aberrant downregulation of lncRNA SULT1C2A leads to reduced Foxo4 expression by increasing miR‐466c‐5p abundance in vitamin A deficiency‐associated congenital scoliosis.

3.6. miR‐15a {#cpr12736-sec-0009}
------------

Li and colleagues studied the morphological changes, histone methylation alterations and cell growth‐related signalling pathway in the inferior facet joint cartilage in 10 control subjects and 11 patients with idiopathic scoliosis.[53](#cpr12736-bib-0053){ref-type="ref"} Patients with idiopathic scoliosis showed increased number of proliferative chondrocytes as well as upregulation of BCL2 and COL2A1 in the facet joint cartilage, which was significantly narrowed. Furthermore, miR‐15a expression was decreased while the trimethylation of histone 3 lysine 9 (H3K9me3: a repressive chromatin mark) in promoter region of miR‐15a‐encoding gene was increased in the idiopathic scoliosis group. Mechanistically, suppressor of variegation 3‐9, drosophila homolog of 1 (SUV39H1) was found to be an upstream regulator that mediates epigenetic silencing of miR‐15a and thereby promoting BCL2 expression and proliferation of chondrogenic cells.

4. CONCLUSION AND FUTURE PERSPECTIVES {#cpr12736-sec-0010}
=====================================

The cellular and molecular pathogenesis of scoliosis is complex, involves multiple aetiologies and depends on varying contributions of biomechanical, neuromuscular, developmental and biochemical abnormalities.[8](#cpr12736-bib-0008){ref-type="ref"}, [29](#cpr12736-bib-0029){ref-type="ref"} Among different subtypes of scoliosis, the ncRNA expression landscape has been relatively well depicted in AIS. Nevertheless, only few of the identified ncRNAs (ie miR‐145, miR‐675‐5p, LncAIS, SULT1C2A, miR‐466c‐5p, miR‐15a) have been functionally verified (Figure [1](#cpr12736-fig-0001){ref-type="fig"} and Table [2](#cpr12736-tbl-0002){ref-type="table"}). These ncRNAs were found to primarily affect processes that are pertinent to the development of musculoskeletal system, including somitogenesis during embryo development, osteogenic differentiation of osteoblasts and bone marrow‐mesenchymal stem cells, paravertebral muscle differentiation and chondrogenesis. Future endeavours should therefore be put forth to characterize the functional roles of other deregulated ncRNAs in relevant cell line and animal models of scoliosis. The importance of ncRNAs should also be assessed in relation to clinicopathological parameters and treatment outcomes, so as to develop novel diagnostic and prognostic markers. In terms of treatment, it would be tantalizing to determine whether scoliosis progression could be prevented through restoring the expression of downregulated ncRNAs or silencing of the aberrantly upregulated ncRNAs. Nevertheless, the best way to deliver ncRNA‐directed therapeutics into specific tissue or cell types remain poorly defined. It is hopeful that, with more translational research in this area, ncRNAs will one day become part of our armamentarium to fight this potentially devastating disease.

![Pathogenic mechanism of deregulated ncRNAs in scoliosis](CPR-53-e12736-g001){#cpr12736-fig-0001}

###### 

Functionally characterized ncRNAs in scoliosis

+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| ncRNAs     | Deregulation  | Functional role                                  | Related genes/loci | References                               |
+============+===============+==================================================+====================+==========================================+
| miR‐4300   | SNPs          | AIS risk progression                             | rs1828853          | [49](#cpr12736-bib-0049){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| miR‐145    | Upregulated   | osteogenic differentiation                       | CTNNB1, TCF4       | [50](#cpr12736-bib-0050){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| H19        | Downregulated | skeletal muscle differentiation and regeneration | ADIPOQ             | [51](#cpr12736-bib-0051){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| miR‐675‐5p | Downregulated | skeletal muscle differentiation and regeneration | ADIPOQ             | [51](#cpr12736-bib-0051){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| LncAIS     | Downregulated | Osteogenic differentiation, Bone formation       | NF90               | [52](#cpr12736-bib-0052){ref-type="ref"} |
|            |               |                                                  |                    |                                          |
|            |               |                                                  | HOXD8              |                                          |
|            |               |                                                  |                    |                                          |
|            |               |                                                  | RUNX2              |                                          |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| SULT1C2A   | Downregulated | Somitogenesis                                    | miR‐466c‐5p, FOXO4 | [43](#cpr12736-bib-0043){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| miR‐466‐5c | Downregulated | Somitogenesis                                    | FOXO4              | [43](#cpr12736-bib-0043){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
| miR‐15a    | Downregulated | Chondrogenesis                                   | BCL2               | [53](#cpr12736-bib-0053){ref-type="ref"} |
+------------+---------------+--------------------------------------------------+--------------------+------------------------------------------+
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